Researchers are finding promise in an mHealth wearable that would improve care management for people diagnosed with atrial fibrillation.
The mobile health device, which attaches to the ear, reportedly uses transcutaneous electrical vagus nerve stimulation to reduce AF burden. Researchers say it’s been used to treat epilepsy and could give those living with AF and their care providers an alternative to medication, surgery or frequent trips to the doctor’s office or hospital.
Andrew Krahn, MD, of the University of British Columbia (UBC) and St. Paul’s Hospital (SPH) in Vancouver, said the treatment could help in care management for people who can’t or don’t want to take medication, don’t adhere to medication therapy or want to avoid ablation.
Read the full story on mHealth Intelligence.